drugset / Trial / NCT01042106
Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of DSP-8658 in patients with Type 2 diabetes mellitus and healthy adults.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DSP-8658 | Unknown | 2.5 mg | Oral |
| Subject | DSP-8658 | Unknown | 10 mg | Oral |
| Subject | DSP-8658 | Unknown | 20 mg | Oral |
| Subject | DSP-8658 | Unknown | 40 mg | Oral |